You are browsing content specific to your location, some treatments may not be available:

Endometrial Receptivity Analysis (ERA)

Endometrial Receptivity Analysis (ERA) is a test to assess the endometrial status and determine the presence of a receptive gene profile in the patient's endometrium during the biopsy.
The human endometrium is a highly dynamic tissue that is capable of undergoing physiological changes in response to steroid hormones. Thus, it creates a receptive status that is synchronized with the arrival of an implanting blastocyst (refers to an embryo that is 5 days old after successful fertilization).

Who should consider ERA?

The ERA is considered in women who:

  • Experienced multiple implantation failures with embryo transfers despite good quality of the embryos
  • No previous pregnancies

What is Endometrial Receptivity Genome Analysis?

Endometrial Receptivity Genome Analysis is a state-of-the-art diagnostic method. This test evaluates the endometrial receptivity status from a molecular point of view. It helps to assess the receptivity for endometrium for implantation by analyzing the expression of a group of genes related to endometrial receptivity.

Types of treatment related to this article

IVF means in vitro fertilization.  In vitro means in the laboratory ( outside the body)  and fertilization refers to conception (joining of a woman’s egg and a

Learn More

Intracytoplasmic sperm injection (ICSI) is a technique developed to overcome male infertility attributed to impaired semen quality.  ICSI is one of the most

Learn More

Preimplantation genetic testing for aneuploidies (PGT‐A), formerly known as preimplantation genetic screening (PGS), is an alternative method to select embryos

Learn More

PGT-SR is a genetic test for detecting inherited chromosomal structural rearrangements in embryos prior to their transfer and enhancing the chance of a

Learn More

we are here to help